U.S. Biotech Stock News

If you are wondering whether Mondelez International at around US$58.27 is a bargain or just fairly priced, you are not alone. The stock has had a mixed run, with a 3.7% gain over the past week, a 5.4% decline over the last 30 days, an 8.6% return year to date, and a 11.2% loss over the past year. Recent headlines have focused on Mondelez International as a global snacks player, with investors weighing brand strength, cost pressures, and consumer demand trends. That context has been important...

Why Olema’s latest earnings and shelf filing matter for investors Olema Pharmaceuticals (OLMA) has drawn fresh attention after reporting fourth quarter and full year 2025 results, along with a new shelf registration of up to US$71.82 million in common stock. The company posted a fourth quarter net loss of US$46.06 million and a full year 2025 net loss of US$162.45 million. It also registered 4,882,586 shares for an ESOP related offering that could affect future dilution and funding...

Key recent performance and what it might mean for investors Revolution Medicines (RVMD) shares have seen mixed recent returns, with a 1 day decline of 0.75%, a 3.4% drop over the past week, and a roughly 9.3% decline over the past month. Over the past 3 months, however, the stock shows a gain of about 14.9%, and year to date it is up roughly 17.1%. This provides investors with a sense of how sentiment has shifted across different time frames. See our latest analysis for Revolution...

In March 2026, Aurinia Pharmaceuticals underwent a sweeping leadership overhaul, with Board Chair Kevin Tang becoming CEO and principal executive officer, joined by new CFO Michael Hearne, COO Ryan Cole, and Chief Scientific Officer Thomas Wei as several prior C-suite leaders departed. This reshuffle consolidates operational control around Tang Capital–linked executives, signaling a potential shift in how Aurinia balances capital allocation, operations, and pipeline priorities. Next, we’ll...

If you are wondering whether Waters at around US$289.16 is starting to look interesting on valuation, this breakdown will help you put the current share price in context. The stock has seen a 3.3% decline over the last 7 days and is down 9.5% over 30 days, with year to date returns of a 24.3% decline and a 20.2% decline over the past year, adding to the sense that expectations and perceived risk have shifted. Recent commentary around Waters has focused on its position within the Life...

In March 2026, RXO expanded its RXO Extra marketplace, adding a premium load-booking experience with white-glove onboarding, concierge support, bonus payments, and deeper discounts for carriers using its fuel card and factoring services. This enhancement strengthens RXO’s carrier value proposition by tying better digital load access and rewards directly to adoption of its financial and fuel programs. We’ll now examine how the new premium load-booking and rewards structure may influence RXO’s...

In March 2026, Critical Metals Corp. filed a US$25.16 million shelf registration for 2,744,062 ordinary shares and appointed veteran international trade attorney and commodities investor Chang Oh Turkmani to its Advisory Board. Her long track record in cross-border commodity deals, infrastructure logistics, and energy projects may influence how investors view Critical Metals’ global growth ambitions and risk management around complex international transactions. Next, we’ll examine how...

Ollie's Bargain Outlet Holdings (NasdaqGM:OLLI) announced a planned merchandising leadership transition. Senior Vice President, General Merchandise Manager, Kevin McLain is set to retire effective May 1, 2026. Longtime merchandising executive Shane Thornton will assume the senior merchandising leadership role following McLain’s retirement. The move is part of the company’s succession planning for a function that sits at the core of Ollie’s closeout and treasure-hunt model. For investors...

If you are wondering whether Installed Building Products at around US$262 per share still offers value after a strong run, the key is to separate price action from underlying worth. The stock is up 1.4% over the last week, has seen a 20.0% decline over the past month, is down 1.9% year to date, yet sits on a 55.8% 1 year return and a 140.8% 3 year return, with a 146.0% return over 5 years. Recent news coverage has focused on Installed Building Products as a specialist in residential and...

Cyclone damage has triggered a significant, extended outage at Chevron’s Wheatstone LNG facility in Australia. The disruption is expected to last for weeks, tightening global LNG supply during an already volatile period for energy markets. The outage affects a key export hub and introduces fresh operational risk for Chevron’s LNG business. For investors watching Chevron, ticker NYSE:CVX, the Wheatstone outage adds a new layer of risk to a stock that has recently seen strong momentum. The...

If you are trying to figure out whether Aura Minerals at around US$70 a share looks expensive or still has room to run, the starting point is understanding how its current price lines up with its fundamentals. The stock has moved sharply in recent periods, with a 14.7% gain over the last 7 days, a 17.0% decline over 30 days, a 40.1% return year to date, and a very large 1 year gain of 281.2% that sits on top of a roughly 11x return over 3 years. Recent news flow around Aura Minerals has...

Earlier this month, Lumen Technologies announced that long-serving board leaders T. Michael Glenn and Hal Stanley Jones will retire after the 2026 Annual Meeting, while General Kevin P. Chilton is set to become Chair and long-time CFO Christopher D. Stansbury has been appointed President as of March 13, 2026. This reshaping of Lumen’s leadership team, separating the CEO and President roles and elevating a finance-focused executive, highlights a governance and operational shift that could...

Owens Corning stock snapshot after recent performance Owens Corning (OC) has drawn fresh attention after a recent share price pullback, with the stock down about 14% over the past month and roughly 7% over the past 3 months. See our latest analysis for Owens Corning. That recent pullback sits within a weaker stretch for Owens Corning, with a 30 day share price return of a 14.3% decline and a 1 year total shareholder return of a 24.9% loss, suggesting momentum has faded after earlier multi...

Why Tradeweb Markets (TW) is on investors’ radar today Tradeweb Markets (TW) has drawn fresh attention after recent share price moves, with the stock down about 1% over the past day and roughly 7% over the past week. Against that shorter term weakness, the company shows a gain in the past 3 months and a positive year to date return. This has prompted some investors to revisit how its electronic marketplaces business and current valuation line up. See our latest analysis for Tradeweb...

Curious whether Johnson Controls International at around US$131 per share still offers value, or if most of the opportunity is already reflected in the price. The stock has posted a 7.3% return year to date, with a 1.2% move over the last week, a 9.0% decline over the past month, and longer term returns of 67.0% over 1 year, 131.1% over 3 years, and 142.6% over 5 years. Recent headlines around large scale energy efficiency projects, smart building solutions, and broader attention on...

Why the PharmaCann settlement matters for IIPR Innovative Industrial Properties (IIPR) has drawn attention after reaching a settlement with PharmaCann to resolve rent default lawsuits, terminate three property leases, and regain possession of facilities in New York, Ohio, and Pennsylvania. See our latest analysis for Innovative Industrial Properties. The PharmaCann settlement lands at a time when momentum in IIPR’s share price is soft in the short term, with a 30 day share price return...

Viking Therapeutics recently completed patient enrollment in its Phase 3 VANQUISH-2 trial of once-weekly subcutaneous VK2735 in roughly 1,000 adults with obesity and type 2 diabetes, a pivotal study running 78 weeks with weight loss as the primary endpoint. This milestone moves VK2735 further along a path already supported by earlier Phase 2 data showing meaningful weight reduction and an encouraging safety profile, directly linking Viking’s pipeline to the rapidly expanding GLP-1/GIP...

Google’s TurboQuant algorithm announcement, which aims to cut AI memory needs, shook semiconductor sentiment. Photronics (PLAB) dropped 6.8% as investors quickly reassessed demand expectations for memory related manufacturing businesses. See our latest analysis for Photronics. That sharp 6.8% drop comes after a stronger run, with the share price showing a 20.11% 90 day return and an 18.53% year to date return, while the 1 year total shareholder return of 92.23% highlights how much sentiment...

Worthington Enterprises (WOR) has put fresh numbers on the table, with third quarter fiscal 2026 results showing higher sales, earnings and earnings per share, supported by acquisitions and data center related demand. See our latest analysis for Worthington Enterprises. The latest earnings update, buyback progress and ongoing dividends come against a mixed share price backdrop, with a 7 day share price return of 6.42% contrasting with a 30 day share price decline of 9.48%, while the 3 year...

Genesis Energy (GEL) is facing a sexual assault lawsuit in Harris County State Court that names the company and a current board member, with Jane Doe seeking US$50 million in compensatory and punitive damages. See our latest analysis for Genesis Energy. The lawsuit lands at a time when Genesis Energy’s share price, now at US$17.78, has pulled back 2.79% over one day but still carries an 11.96% year to date share price return and an 18.10% one year total shareholder return. This builds on a...

Recent Performance Snapshot Merchants Bancorp (MBIN) has drawn fresh attention after a mixed short term return pattern, with a 2.2% decline over the past day, a 2.6% gain over the past week, and a flat month. See our latest analysis for Merchants Bancorp. Looking beyond the latest moves, the 90 day share price return of 26.44% sits alongside a 1 year total shareholder return of 15.44%. This suggests recent momentum has been stronger than the longer term outcome. If you are comparing Merchants...

If you are wondering whether BlackRock's current share price reflects its true value, you are not alone. This article focuses exactly on that question. The stock last closed at US$933.85, with returns of 0.7% over 1 year, 49.8% over 3 years, and 37.2% over 5 years, while the year to date return sits at a 13.9% decline and the past month shows a 12.2% decline. Recent coverage has centered on BlackRock's role as a major global asset manager, its influence across exchange traded funds, and its...

If you are wondering whether Flowserve's current share price still offers value, it helps to look past the headline moves and focus on what the underlying numbers are saying about the stock. The share price recently closed at US$72.15, with returns of 1.1% over 7 days, a 18.5% decline over 30 days, 2.0% year to date, 50.0% over 1 year, 123.1% over 3 years, and 102.4% over 5 years. This gives a mixed picture of shorter term swings versus longer term performance. Recent coverage around...

Genpact stock moves: recent performance snapshot Genpact (G) has drawn investor attention after a period of weaker share performance, with the stock showing a 2.2% decline over the past day and deeper losses over the past month and past 3 months. See our latest analysis for Genpact. At a share price of US$36.58, Genpact’s recent 7 day and 30 day share price returns of 5.48% and 7.91% declines, alongside a 1 year total shareholder return of 25.62% decline, suggest momentum has been fading as...